BlackRock Health Sciences Trust (NYSE:BME) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why

BlackRock Health Sciences Trust (NYSE:BME – Get Free Report)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $41.87 and traded as high as $43.71. BlackRock Health Sciences Trust shares last traded at $43.43, with a volume of 46,927 shares changing hands.

BlackRock Health Sciences Trust Trading Up 0.6%

The business’s 50-day moving average price is $41.87 and its two-hundred day moving average price is $40.89.

Get BlackRock Health Sciences Trust alerts:

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a dividend of $0.2621 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) annualized dividend and a yield of 7.2%.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

A number of hedge funds have recently modified their holdings of BME. Sound Income Strategies LLC acquired a new position in shares of BlackRock Health Sciences Trust in the first quarter valued at approximately $36,000. Northwestern Mutual Wealth Management Co. boosted its stake in BlackRock Health Sciences Trust by 22.2% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares during the period. Geneos Wealth Management Inc. increased its holdings in BlackRock Health Sciences Trust by 200.0% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after purchasing an additional 3,266 shares in the last quarter. Fifth Third Bancorp acquired a new stake in shares of BlackRock Health Sciences Trust in the 1st quarter valued at about $180,000. Finally, Money Concepts Capital Corp bought a new stake in shares of BlackRock Health Sciences Trust in the first quarter valued at about $209,000.

BlackRock Health Sciences Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.

Featured Stories

• Five stocks we like better than BlackRock Health Sciences Trust
• SpaceX: Love the Company, But the Stock Is a Harder Call
• Ulta’s Growth Is Real, But So Are the Risks
• BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
• Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.